Published in AIDS Weekly, November 24th, 1997
The patent was issued to Verex Laboratories, Inc., Englewood, Colorado.
James M. Dunn, M.D., Verex, commented, "We are quite pleased with the issuance of this patent which we believes continues to substantiate the progress that we have made in our HIV and AIDS treatment program. In the past year, we have completed Phase III clinical trials on this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.